Courtney M P Hollowell Selected Research

1,2-dielaidoylphosphatidylethanolamine (Lipofectin)

6/2012	Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.
9/2011	Bax expression remains unchanged following antisense treatment directed against BCL-2.
12/2010	Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Courtney M P Hollowell Research Topics

Disease

22	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2010
15	Neoplasms (Cancer) 01/2022 - 12/2010
6	Wounds and Injuries (Trauma) 01/2021 - 06/2009
3	Vitamin D Deficiency 01/2021 - 09/2012
2	Disease Progression 01/2021 - 01/2018
1	Fatigue 01/2022
1	Gynecomastia 01/2022
1	Rupture 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Vesicovaginal Fistula 03/2018
1	Foreign Bodies (Foreign Body) 11/2016
1	7 Hereditary Prostate Cancer 04/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2015
1	Lymphoma (Lymphomas) 11/2015
1	Fournier Gangrene 04/2013
1	Carcinogenesis 01/2013
1	Hydropneumothorax 04/2012
1	Virus Diseases (Viral Diseases) 03/2011
1	Carcinoma (Carcinomatosis) 09/2010
1	Pathologic Constriction (Stenosis) 10/2002

Drug/Important Bio-Agent (IBA)

14	Antisense OligonucleotidesIBA 11/2015 - 12/2010
10	Proteins (Proteins, Gene)FDA Link 11/2015 - 04/2011
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 11/2019
4	Vitamin D FDA LinkGeneric 01/2017 - 09/2012
4	AndrogensIBA 09/2014 - 09/2012
3	1,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA 06/2012 - 12/2010
2	AntigensIBA 11/2015 - 03/2011
2	Surface Antigens (Surface Antigen)IBA 06/2012 - 01/2011
1	enzalutamideIBA 01/2022
1	hydroxide ionIBA 01/2021
1	CarbohydratesIBA 03/2019
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 03/2019
1	Sucrose (Saccharose)IBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Gemcitabine FDA Link 01/2018
1	CalciumIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	OligonucleotidesIBA 11/2015
1	CyclinsIBA 11/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Insulin-Like PeptidesIBA 09/2012
1	Interleukin-4 (Interleukin 4)IBA 09/2012
1	Biological ProductsIBA 09/2012
1	Cancer VaccinesIBA 06/2012
1	Antiviral Agents (Antivirals)IBA 03/2011
1	Differentiation AntigensIBA 01/2011
1	VaccinesIBA 01/2011
1	CytokinesIBA 12/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2010
2	Orchiectomy (Orchidectomy) 01/2021 - 03/2012
2	Urinary Diversion (Ileal Conduit) 03/2013 - 10/2002
2	Nephrectomy 11/2011 - 09/2011
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Castration 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 03/2019
1	Intrauterine Devices (Intrauterine Device) 03/2018
1	Radiotherapy 01/2018
1	Cystotomy 11/2016
1	Length of Stay 04/2013
1	Percutaneous Nephrolithotomy 04/2012
1	Operative Surgical Procedures 06/2009
1	Autologous Transplantation 10/2002
1	Cystectomy 10/2002